Venus Remedies Limited

BSE: 526953 NSE: VENUSREM
Venus Remedies Limited - pharma in Chandigarh, Chandigarh, India. FY 2026 financials and compliance.
CIN L24232CH1989PLC009705 Incorporated 15 September 1989 ROC Chandigarh HQ Chandigarh, Chandigarh, India
Active Listed - NSE: VENUSREM · BSE: 526953 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹769.6 Cr
▲ 18.79% YoY
Computed EBITDA · FY 2026
₹159.86 Cr
▲ 89.18% YoY
Net profit · FY 2026
₹102.78 Cr
▲ 126.79% YoY
Authorised capital
₹20 Cr
Registered with MCA
Paid-up capital
₹13.37 Cr
Issued & subscribed
Open charges
None
Satisfied ₹909.48 Cr
Company age
37 yrs
Est. 1989
Employees · EPFO
1,119
Latest available

About Venus Remedies Limited

Data last updated: 02 June 2026

Venus Remedies Limited is a public limited company based in Chandigarh, Chandigarh, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 15 September 1989, the company has been in operation for over 37 years.

Registered with ROC Chandigarh under CIN L24232CH1989PTC009705. Listed on BSE: 526953 and NSE: VENUSREM.

Capital: an authorised share capital of ₹20 Cr and a paid-up capital of ₹13.37 Cr. Formerly known as Venus Glucose Private Limited. It is led by directors including Manu Chaudhary and Peeyush Jain.

Last AGM: 22 August 2025. Financial statements filed for year ended 31 March 2025. Office: Sco 857 2Nd Floor C. No. 10 Nac Manimajra, Chandigarh, Chandigarh, India – 160101.

As per NSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹769.6 Cr, a growth of 18.79% compared to the previous year. The net worth stands at ₹663.75 Cr (up 18.33% YoY). Total assets are valued at ₹853.71 Cr (up 19.28% YoY).

The company has a workforce of approximately 1,119 employees as per the latest available data.

The company is associated with 2 brands - Venus Medicine Research Center, Venus Remedies. As per MCA filings, the company has satisfied charges of ₹909.48 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website venusremedies.com.

Company Details of Venus Remedies Limited
CIN L24232CH1989PLC009705
Registration Number 009705
Incorporation Date 15 September 1989
ROC Chandigarh
Listing Status Listed (BSE: 526953, NSE: VENUSREM)
Company Status Active
Date of Last AGM 22 August 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Pawan Chaudhary Managing Director Manu Chaudhary Whole-Time Director Peeyush Jain Whole-Time Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
  • Registered Address
    Sco 857 2Nd Floor C. No. 10 Nac Manimajra, Chandigarh, Chandigarh, India – 160101
  • Industry
    Pharma, Drug Formulation & Development
Company report
Venus Remedies Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Venus Remedies Limited report

Financials, compliance, directors, charges, ownership and filings for Venus Remedies Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Venus Remedies Limited

Venus Remedies Limited has one previous CIN (Corporate Identification Number): L24232CH1989PTC009705. The current CIN is L24232CH1989PLC009705, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L24232CH1989PLC009705 Current
L24232CH1989PTC009705 Previous

Associated Brands with Venus Remedies Limited

Venus Remedies Limited operates two associated brands: Venus Medicine Research Center and Venus Remedies. These brands represent Venus Remedies Limited's diversified market presence and brand portfolio.

Brand Description Website
Venus Medicine Research Center
Delivers specialized bio-analytical services for drug development and research applications. vmrcindia.com
Venus Remedies
Research-based generic and antibiotic pharmaceuticals are manufactured. venusremedies.com

Business Activity of Venus Remedies Limited

Venus Remedies Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Venus Remedies Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Venus Remedies Limited

Venus Remedies Limited is audited by J K Jain Associates (ICAI peer reviewed, certificate valid till 2027-04-30) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
J K Jain Associates (ICAI peer reviewed, certificate valid till 2027-04-30) FY 2026 Declaration of unmodified opinion

Board of Directors of Venus Remedies Limited

Venus Remedies Limited is currently managed by 10 directors, with 13 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Manu Chaudhary
Also directs: Sunev Pharma Solutions Limited
Whole-Time Director 10 Oct 2005 20 Years 9 Months Current
Peeyush Jain
Also directs: Spine Software Systems Private Limited
Whole-Time Director 28 Sep 1994 31 Years 9 Months Current
Ashutosh Jain
Also directs: Sunev Pharma Solutions Limited
Whole-Time Director 01 May 2007 19 Years 2 Months Current
Pawan Chaudhary
Also directs: Sunev Pharma Solutions Limited, Spine Software Systems Private Limited
Managing Director 15 Sep 1989 36 Years 10 Months Current
Navdeep Sud Director 20 Jun 2020 6 Years 1 Months Current
Savita Gupta
Also directs: Itfy Info Solutions Private Limited
Director 30 Dec 2021 4 Years 6 Months Current
Showing 6 of 10 current directors. View all directors

Financials of Venus Remedies Limited FY 2026 filings available

Venus Remedies Limited reported revenue of ₹769.6 Cr (up 18.79% YoY) for FY 2026.

Revenue · FY 2026
₹769.6 Cr ▲ 18.79%
Profit · FY 2026
₹102.78 Cr ▲ 126.79%
Computed EBITDA · FY 2026
₹159.86 Cr ▲ 89.18%
Revenue₹ Cr · Consolidated05001,000FY 2020: ₹341 Cr341FY 2020FY 2021: ₹548 Cr · +60.5% YoY548+60.5%FY 2021FY 2022: ₹599 Cr · +9.2% YoY599+9.2%FY 2022FY 2023: ₹556 Cr · -7.2% YoY556-7.2%FY 2023FY 2024: ₹601 Cr · +8.3% YoY601+8.3%FY 2024FY 2025: ₹648 Cr · +7.7% YoY648+7.7%FY 2025FY 2026: ₹770 Cr · +18.8% YoY770+18.8%FY 2026
Net Profit₹ Cr · Consolidated-50050100150FY 2020: ₹10 Cr (loss)-10FY 2020FY 2021: ₹62 Cr · +717.8% YoY61.8+717.8%FY 2021FY 2022: ₹41 Cr · -34.1% YoY40.7-34.1%FY 2022FY 2023: ₹27 Cr · -34.8% YoY26.6-34.8%FY 2023FY 2024: ₹28 Cr · +7.2% YoY28.5+7.2%FY 2024FY 2025: ₹45 Cr · +59% YoY45.3+59%FY 2025FY 2026: ₹103 Cr · +126.8% YoY103+126.8%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0100200300Q1'25: ₹109 Cr · +14.1% YoY109+14.1%Q1'25Q2'25: ₹167 Cr · -0.2% YoY167-0.2%Q2'25Q3'25: ₹177 Cr · +23.3% YoY177+23.3%Q3'25Q4'25: ₹195 Cr · -0.1% YoY195-0.1%Q4'25Q1'26: ₹132 Cr · +21.4% YoY132+21.4%Q1'26Q2'26: ₹193 Cr · +15.1% YoY193+15.1%Q2'26Q3'26: ₹180 Cr · +1.9% YoY180+1.9%Q3'26Q4'26: ₹259 Cr · +33% YoY259+33%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹769.6 Cr ₹647.89 Cr ₹601.45 Cr ₹555.51 Cr ₹598.65 Cr ₹548.12 Cr ₹341.46 Cr
Other Income ₹12.58 Cr ₹20.96 Cr ₹11.58 Cr ₹10.32 Cr ₹8.31 Cr ₹19.63 Cr ₹5.31 Cr
Total Income ₹782.18 Cr ₹668.85 Cr ₹613.03 Cr ₹565.83 Cr ₹606.96 Cr ₹567.75 Cr ₹346.77 Cr
Cost of Materials Consumed ₹387.98 Cr ₹348.77 Cr ₹344.28 Cr ₹317.79 Cr ₹381.97 Cr ₹347.94 Cr ₹168.46 Cr
Purchases of Stock-in-Trade ₹10.76 Cr ₹25.04 Cr ₹13.07 Cr ₹5.16 Cr ₹0 ₹0 ₹0
Changes in Inventories -₹11.47 Cr ₹4.81 Cr -₹2.66 Cr ₹8.04 Cr ₹3.48 Cr -₹7.15 Cr ₹5.86 Cr
Employee Benefit Expense ₹88.68 Cr ₹80.49 Cr ₹71.5 Cr ₹61.33 Cr ₹52.33 Cr ₹46.02 Cr ₹46.02 Cr
Finance Costs ₹4 Lakh ₹7 Lakh ₹9.4 Lakh ₹29 Lakh ₹48.1 Lakh ₹13.02 Cr ₹13.34 Cr
Depreciation & Amortisation ₹25.67 Cr ₹22.51 Cr ₹26.44 Cr ₹32.3 Cr ₹33.53 Cr ₹35.28 Cr ₹32.01 Cr
Other Expenses ₹146.37 Cr ₹125.24 Cr ₹115.66 Cr ₹102.99 Cr ₹98.76 Cr ₹107.54 Cr ₹80.31 Cr
Total Expenses ₹648.03 Cr ₹606.93 Cr ₹568.38 Cr ₹527.9 Cr ₹570.55 Cr ₹542.64 Cr ₹345.99 Cr
Profit Before Exceptional Items & Tax ₹134.15 Cr ₹61.92 Cr ₹44.65 Cr ₹37.93 Cr ₹36.41 Cr ₹25.11 Cr ₹77.8 Lakh
Exceptional Items ₹0 ₹9.91 Cr ₹0 ₹0 ₹0 ₹23.44 Cr -₹8.81 Cr
Profit Before Tax ₹134.15 Cr ₹71.83 Cr ₹44.65 Cr ₹37.93 Cr ₹36.41 Cr ₹48.55 Cr -₹8.03 Cr
Total Tax Expense ₹31.37 Cr ₹23.58 Cr ₹16.15 Cr ₹11.36 Cr -₹4.32 Cr -₹13.21 Cr ₹1.96 Cr
Net Profit ₹102.78 Cr ₹45.32 Cr ₹28.5 Cr ₹26.57 Cr ₹40.72 Cr ₹61.77 Cr -₹10 Cr
  attributable to Owners ₹0 - ₹27.22 Cr ₹0 ₹0 ₹0 ₹0
  attributable to NCI ₹0 - ₹0 ₹0 ₹0 ₹0 ₹0
Other Comprehensive Income ₹1 Lakh -₹68 Lakh -₹1.28 Cr -₹6.71 Cr -₹56.2 Lakh -₹9.5 Lakh -₹47.2 Lakh
Total Comprehensive Income ₹102.79 Cr ₹44.64 Cr ₹27.22 Cr ₹19.86 Cr ₹40.16 Cr ₹61.67 Cr -₹10.47 Cr
EBITDA (computed) ₹159.86 Cr ₹84.5 Cr ₹71.18 Cr ₹70.52 Cr ₹70.42 Cr ₹73.41 Cr ₹46.13 Cr
Basic EPS ₹76.89 ₹33.90 ₹21.31 ₹19.88 ₹30.86 ₹50.04 ₹-8.10
Diluted EPS ₹76.89 ₹33.90 ₹21.31 ₹19.88 ₹30.86 ₹50.04 ₹-8.10
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹853.71 Cr ₹715.72 Cr ₹626.83 Cr ₹601.08 Cr
Non-current Assets ₹458.5 Cr ₹264 Cr ₹267.3 Cr ₹278.12 Cr
Current Assets ₹395.21 Cr ₹451.72 Cr ₹359.53 Cr ₹322.96 Cr
Property, Plant & Equipment ₹125.43 Cr ₹124.7 Cr ₹133.32 Cr ₹136.72 Cr
Inventories ₹129.37 Cr ₹100.49 Cr ₹121.69 Cr ₹119.94 Cr
Trade Receivables ₹103.28 Cr ₹112.22 Cr ₹80.5 Cr ₹76.66 Cr
Cash & Equivalents ₹25.12 Cr ₹57.52 Cr ₹48.96 Cr ₹21.21 Cr
Equity (Net Worth) ₹663.75 Cr ₹560.95 Cr ₹487.55 Cr ₹460.34 Cr
Equity Share Capital ₹13.37 Cr ₹13.37 Cr ₹13.37 Cr ₹13.37 Cr
Borrowings (Non-current) ₹0 ₹0 ₹38.68 Cr ₹38.68 Cr
Borrowings (Current) ₹0 ₹1.69 Cr ₹2.65 Cr ₹3.61 Cr
Total Debt (computed) ₹0 ₹1.69 Cr ₹41.33 Cr ₹42.29 Cr
Current Liabilities ₹161.76 Cr ₹136.29 Cr ₹79.42 Cr ₹82.57 Cr
Total Liabilities ₹189.96 Cr ₹154.77 Cr ₹139.28 Cr ₹140.74 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹155.76 Cr ₹86.45 Cr ₹37.28 Cr ₹36.62 Cr ₹41 Cr
Investing Cash Flow -₹181.56 Cr -₹76.25 Cr -₹7.21 Cr -₹50.83 Cr -₹16.63 Cr
Financing Cash Flow -₹3.12 Cr -₹1.02 Cr -₹1.08 Cr -₹57 Lakh -₹9.48 Cr
Capital Expenditure ₹37.65 Cr ₹9.63 Cr ₹9.32 Cr ₹7.82 Cr ₹13.71 Cr
Free Cash Flow (computed) ₹118.11 Cr ₹76.82 Cr ₹27.96 Cr ₹28.8 Cr ₹27.29 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash -₹32.41 Cr ₹8.56 Cr ₹27.74 Cr -₹22.05 Cr ₹14.38 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹259.4 Cr ₹180.26 Cr ₹192.75 Cr ₹131.9 Cr ₹194.97 Cr ₹176.86 Cr ₹167.45 Cr ₹108.61 Cr ₹195.16 Cr ₹143.42 Cr ₹167.72 Cr ₹95.15 Cr
Other Income ₹4.95 Cr ₹2.52 Cr ₹1.71 Cr ₹8.69 Cr ₹6.76 Cr ₹2.03 Cr ₹10.58 Cr ₹1.59 Cr ₹3.92 Cr ₹2.35 Cr ₹3.05 Cr ₹2.26 Cr
Total Income ₹264.35 Cr ₹182.78 Cr ₹194.46 Cr ₹140.59 Cr ₹201.73 Cr ₹178.89 Cr ₹178.03 Cr ₹110.2 Cr ₹199.08 Cr ₹145.77 Cr ₹170.77 Cr ₹97.41 Cr
Cost of Materials Consumed ₹116.28 Cr ₹93.86 Cr ₹106.51 Cr ₹71.33 Cr ₹104.21 Cr ₹97.52 Cr ₹77.46 Cr ₹69.58 Cr ₹84.17 Cr ₹87.31 Cr ₹95.17 Cr ₹77.63 Cr
Purchases of Stock-in-Trade ₹4.73 Cr ₹1.9 Cr ₹1.86 Cr ₹2.27 Cr ₹2.13 Cr ₹5.5 Cr ₹8.38 Cr ₹9.03 Cr ₹2.67 Cr ₹2.63 Cr ₹4.6 Cr ₹3.17 Cr
Changes in Inventories -₹1.45 Cr -₹9.51 Cr -₹1.06 Cr ₹55 Lakh -₹3.28 Cr ₹7.18 Cr ₹21.89 Cr -₹20.98 Cr ₹33.2 Cr -₹75 Lakh -₹2.25 Cr -₹32.86 Cr
Employee Benefit Expense ₹24.56 Cr ₹20.83 Cr ₹22.97 Cr ₹20.3 Cr ₹21.16 Cr ₹19.55 Cr ₹21.57 Cr ₹18.21 Cr ₹19.71 Cr ₹17.35 Cr ₹18.51 Cr ₹15.94 Cr
Finance Costs ₹1 Lakh ₹1 Lakh ₹1 Lakh ₹1 Lakh ₹1 Lakh ₹1 Lakh ₹2 Lakh ₹2 Lakh ₹2 Lakh ₹7 Lakh ₹6 Lakh ₹6 Lakh
Depreciation & Amortisation ₹6.76 Cr ₹6.56 Cr ₹6.17 Cr ₹6.18 Cr ₹4.71 Cr ₹5.41 Cr ₹6.4 Cr ₹5.98 Cr ₹5.91 Cr ₹6.54 Cr ₹6.44 Cr ₹7.55 Cr
Other Expenses ₹51.86 Cr ₹35.66 Cr ₹31.51 Cr ₹27.34 Cr ₹41.75 Cr ₹28.75 Cr ₹33.24 Cr ₹21.51 Cr ₹35.94 Cr ₹24.84 Cr ₹33.9 Cr ₹20.87 Cr
Total Expenses ₹202.75 Cr ₹149.31 Cr ₹167.97 Cr ₹127.98 Cr ₹170.69 Cr ₹163.92 Cr ₹168.96 Cr ₹103.35 Cr ₹181.62 Cr ₹137.99 Cr ₹156.43 Cr ₹92.36 Cr
Profit Before Exceptional Items & Tax ₹61.6 Cr ₹33.47 Cr ₹26.49 Cr ₹12.61 Cr ₹31.04 Cr ₹14.97 Cr ₹9.08 Cr ₹6.85 Cr ₹17.47 Cr ₹7.78 Cr ₹14.34 Cr ₹5.05 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹9.91 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹61.6 Cr ₹33.47 Cr ₹26.49 Cr ₹12.61 Cr ₹31.04 Cr ₹24.88 Cr ₹9.08 Cr ₹6.85 Cr ₹17.47 Cr ₹7.78 Cr ₹14.34 Cr ₹5.05 Cr
Total Tax Expense ₹14.11 Cr ₹7.89 Cr ₹6.36 Cr ₹3.01 Cr ₹7.11 Cr ₹5.28 Cr ₹5.56 Cr ₹5.63 Cr ₹6.96 Cr ₹93 Lakh ₹4.4 Cr ₹3.87 Cr
Net Profit ₹47.49 Cr ₹25.58 Cr ₹20.13 Cr ₹9.6 Cr ₹21 Cr ₹19.6 Cr ₹3.52 Cr ₹1.22 Cr ₹10.51 Cr ₹6.85 Cr ₹9.94 Cr ₹1.18 Cr
  attributable to Owners ₹0 ₹0 ₹0 ₹0 - ₹0 ₹0 ₹0 ₹10.83 Cr ₹0 ₹0 ₹0
  attributable to NCI ₹0 ₹0 ₹0 ₹0 - ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Other Comprehensive Income -₹5.49 Cr ₹1.9 Cr ₹1.26 Cr ₹2.36 Cr -₹81 Lakh -₹1.75 Cr ₹1.84 Cr ₹4 Lakh ₹33 Lakh -₹1.14 Cr -₹12 Lakh -₹36 Lakh
Total Comprehensive Income ₹42 Cr ₹27.48 Cr ₹21.39 Cr ₹11.96 Cr ₹20.19 Cr ₹17.85 Cr ₹5.35 Cr ₹1.26 Cr ₹10.84 Cr ₹5.71 Cr ₹9.82 Cr ₹82 Lakh
EBITDA (computed) ₹68.37 Cr ₹40.04 Cr ₹32.67 Cr ₹18.8 Cr ₹35.76 Cr ₹20.39 Cr ₹15.5 Cr ₹12.85 Cr ₹23.4 Cr ₹14.39 Cr ₹20.84 Cr ₹12.66 Cr
Basic EPS ₹35.53 ₹19.14 ₹15.06 ₹7.18 ₹15.71 ₹14.66 ₹2.63 ₹0.92 ₹7.86 ₹5.13 ₹7.44 ₹0.88
Diluted EPS ₹35.53 ₹19.14 ₹22.24 ₹7.18 ₹15.71 ₹14.66 ₹2.63 ₹0.92 ₹7.86 ₹5.13 ₹7.44 ₹0.88
Latest 12 quarters shown of 24 on record.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹768.73 Cr ₹639.46 Cr ₹575.21 Cr ₹537.66 Cr ₹575.18 Cr ₹514.62 Cr ₹341.46 Cr
Other Income ₹11.45 Cr ₹20.78 Cr ₹11.32 Cr ₹10.17 Cr ₹8.43 Cr ₹17.76 Cr ₹5.31 Cr
Total Income ₹780.18 Cr ₹660.24 Cr ₹586.53 Cr ₹547.83 Cr ₹583.61 Cr ₹532.39 Cr ₹346.77 Cr
Cost of Materials Consumed ₹387.95 Cr ₹348.82 Cr ₹344.15 Cr ₹317.28 Cr ₹372.78 Cr ₹344.04 Cr ₹168.46 Cr
Purchases of Stock-in-Trade ₹10.76 Cr ₹25.04 Cr ₹13.07 Cr ₹5.16 Cr ₹0 ₹0 ₹0
Changes in Inventories -₹11.47 Cr ₹93 Lakh -₹5 Cr ₹14.26 Cr ₹3.19 Cr -₹7.36 Cr ₹5.86 Cr
Employee Benefit Expense ₹84.85 Cr ₹72.24 Cr ₹62.13 Cr ₹51.95 Cr ₹43.75 Cr ₹35.89 Cr ₹46.02 Cr
Finance Costs ₹0 ₹0 ₹0 ₹0 ₹0 ₹12.73 Cr ₹13.34 Cr
Depreciation & Amortisation ₹24.69 Cr ₹21.62 Cr ₹25.55 Cr ₹31.37 Cr ₹32.58 Cr ₹34.28 Cr ₹32.01 Cr
Other Expenses ₹152.72 Cr ₹122.44 Cr ₹99.98 Cr ₹87.48 Cr ₹86.65 Cr ₹95.18 Cr ₹80.31 Cr
Total Expenses ₹649.5 Cr ₹591.09 Cr ₹539.88 Cr ₹507.5 Cr ₹538.94 Cr ₹514.77 Cr ₹345.99 Cr
Profit Before Exceptional Items & Tax ₹130.68 Cr ₹69.15 Cr ₹46.65 Cr ₹40.33 Cr ₹44.67 Cr ₹17.62 Cr ₹77.8 Lakh
Exceptional Items ₹0 ₹9.91 Cr ₹0 ₹0 ₹0 ₹23.44 Cr -₹8.81 Cr
Profit Before Tax ₹130.68 Cr ₹79.06 Cr ₹46.65 Cr ₹40.33 Cr ₹44.67 Cr ₹41.06 Cr -₹8.03 Cr
Total Tax Expense ₹31.37 Cr ₹23.58 Cr ₹16.15 Cr ₹11.37 Cr -₹4.32 Cr -₹13.21 Cr ₹1.96 Cr
Net Profit ₹99.31 Cr ₹52.55 Cr ₹30.5 Cr ₹28.96 Cr ₹48.99 Cr ₹54.27 Cr -₹10 Cr
  attributable to Owners - - - - - - ₹0
  attributable to NCI - - - - - - ₹0
Other Comprehensive Income ₹83 Lakh -₹43 Lakh ₹4 Lakh -₹36 Lakh ₹24.4 Lakh -₹9.5 Lakh -₹47.2 Lakh
Total Comprehensive Income ₹100.14 Cr ₹52.12 Cr ₹30.54 Cr ₹28.6 Cr ₹49.23 Cr ₹54.18 Cr -₹10.47 Cr
EBITDA (computed) ₹155.37 Cr ₹90.77 Cr ₹72.2 Cr ₹71.7 Cr ₹77.25 Cr ₹64.63 Cr ₹46.13 Cr
Basic EPS ₹74.29 ₹39.32 ₹22.82 ₹24.67 ₹37.12 ₹43.97 ₹-8.10
Diluted EPS ₹74.29 ₹39.32 ₹22.82 ₹21.67 ₹37.12 ₹43.97 ₹-8.10
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹876.06 Cr ₹713.22 Cr ₹641.26 Cr ₹608.89 Cr
Non-current Assets ₹470.25 Cr ₹277.47 Cr ₹280.26 Cr ₹290.58 Cr
Current Assets ₹405.81 Cr ₹435.75 Cr ₹361 Cr ₹318.31 Cr
Property, Plant & Equipment ₹110.23 Cr ₹110.93 Cr ₹119.03 Cr ₹121.9 Cr
Inventories ₹129.37 Cr ₹100.49 Cr ₹117.81 Cr ₹113.6 Cr
Trade Receivables ₹116.39 Cr ₹99.26 Cr ₹89.54 Cr ₹84.91 Cr
Cash & Equivalents ₹23.54 Cr ₹55.41 Cr ₹48.51 Cr ₹20.07 Cr
Equity (Net Worth) ₹689.63 Cr ₹589.5 Cr ₹508.59 Cr ₹478.05 Cr
Equity Share Capital ₹13.37 Cr ₹13.37 Cr ₹13.37 Cr ₹13.37 Cr
Borrowings (Non-current) ₹0 ₹0 ₹38.68 Cr ₹38.68 Cr
Borrowings (Current) ₹0 ₹0 ₹0 ₹0
Total Debt (computed) ₹0 ₹0 ₹38.68 Cr ₹38.68 Cr
Current Liabilities ₹158.23 Cr ₹105.24 Cr ₹72.81 Cr ₹72.67 Cr
Total Liabilities ₹186.43 Cr ₹123.72 Cr ₹132.67 Cr ₹130.84 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹151.09 Cr ₹83.1 Cr ₹35.38 Cr ₹28.05 Cr ₹40.9 Cr
Investing Cash Flow -₹181.57 Cr -₹76.2 Cr -₹6.95 Cr -₹50.81 Cr -₹16.65 Cr
Financing Cash Flow -₹1.39 Cr ₹0 ₹0 ₹0 -₹9.13 Cr
Capital Expenditure ₹37.66 Cr ₹9.58 Cr ₹9.05 Cr ₹7.8 Cr ₹13.68 Cr
Free Cash Flow (computed) ₹113.43 Cr ₹73.52 Cr ₹26.33 Cr ₹20.25 Cr ₹27.22 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash -₹31.87 Cr ₹6.9 Cr ₹28.43 Cr -₹22.76 Cr ₹15.12 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹259.01 Cr ₹179.95 Cr ₹192.65 Cr ₹131.85 Cr ₹194.04 Cr ₹172.54 Cr ₹167.02 Cr ₹105.86 Cr ₹175.16 Cr ₹131.23 Cr ₹170.19 Cr ₹98.63 Cr
Other Income ₹4.64 Cr ₹2.41 Cr ₹1.68 Cr ₹8 Cr ₹6.77 Cr ₹1.74 Cr ₹10.71 Cr ₹1.56 Cr ₹3.91 Cr ₹2.42 Cr ₹2.93 Cr ₹2.06 Cr
Total Income ₹263.65 Cr ₹182.36 Cr ₹194.33 Cr ₹139.85 Cr ₹200.81 Cr ₹174.28 Cr ₹177.73 Cr ₹107.42 Cr ₹179.07 Cr ₹133.65 Cr ₹173.12 Cr ₹100.69 Cr
Cost of Materials Consumed ₹116.25 Cr ₹93.86 Cr ₹106.51 Cr ₹71.33 Cr ₹104.21 Cr ₹97.61 Cr ₹77.41 Cr ₹69.59 Cr ₹89.54 Cr ₹87.21 Cr ₹95.18 Cr ₹72.23 Cr
Purchases of Stock-in-Trade ₹4.73 Cr ₹1.9 Cr ₹1.87 Cr ₹2.27 Cr ₹2.13 Cr ₹5.5 Cr ₹8.38 Cr ₹9.03 Cr ₹2.67 Cr ₹2.63 Cr ₹4.6 Cr ₹3.17 Cr
Changes in Inventories -₹1.45 Cr -₹9.51 Cr -₹1.06 Cr ₹55 Lakh -₹4 Cr ₹2.38 Cr ₹23.85 Cr -₹21.3 Cr ₹12.79 Cr -₹6.87 Cr ₹10.17 Cr -₹21.09 Cr
Employee Benefit Expense ₹23.62 Cr ₹19.94 Cr ₹22.03 Cr ₹19.26 Cr ₹19.32 Cr ₹17.39 Cr ₹19.45 Cr ₹16.08 Cr ₹17.21 Cr ₹15.12 Cr ₹16.25 Cr ₹13.55 Cr
Finance Costs ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Depreciation & Amortisation ₹6.5 Cr ₹6.32 Cr ₹5.92 Cr ₹5.95 Cr ₹4.49 Cr ₹5.2 Cr ₹6.17 Cr ₹5.76 Cr ₹5.72 Cr ₹6.3 Cr ₹6.21 Cr ₹7.32 Cr
Other Expenses ₹56.42 Cr ₹37.04 Cr ₹33.46 Cr ₹25.79 Cr ₹49.83 Cr ₹26.75 Cr ₹27.68 Cr ₹18.18 Cr ₹31.68 Cr ₹20.14 Cr ₹30.86 Cr ₹17.3 Cr
Total Expenses ₹206.07 Cr ₹149.55 Cr ₹168.73 Cr ₹125.15 Cr ₹175.98 Cr ₹154.83 Cr ₹162.92 Cr ₹97.34 Cr ₹159.6 Cr ₹124.53 Cr ₹163.27 Cr ₹92.48 Cr
Profit Before Exceptional Items & Tax ₹57.58 Cr ₹32.81 Cr ₹25.6 Cr ₹14.7 Cr ₹24.83 Cr ₹19.45 Cr ₹14.81 Cr ₹10.08 Cr ₹19.48 Cr ₹9.12 Cr ₹9.85 Cr ₹8.21 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹9.91 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹57.58 Cr ₹32.81 Cr ₹25.6 Cr ₹14.7 Cr ₹24.83 Cr ₹29.36 Cr ₹14.81 Cr ₹10.08 Cr ₹19.48 Cr ₹9.12 Cr ₹9.85 Cr ₹8.21 Cr
Total Tax Expense ₹14.11 Cr ₹7.89 Cr ₹6.36 Cr ₹3.01 Cr ₹7.11 Cr ₹5.28 Cr ₹5.55 Cr ₹5.63 Cr ₹6.96 Cr ₹93 Lakh ₹4.4 Cr ₹3.87 Cr
Net Profit ₹43.47 Cr ₹24.92 Cr ₹19.24 Cr ₹11.69 Cr ₹14.79 Cr ₹24.08 Cr ₹9.26 Cr ₹4.45 Cr ₹12.52 Cr ₹8.19 Cr ₹5.45 Cr ₹4.34 Cr
Other Comprehensive Income -₹5.48 Cr ₹2.19 Cr ₹51 Lakh ₹3.61 Cr -₹61 Lakh -₹2.11 Cr ₹2.11 Cr ₹18 Lakh ₹16 Lakh ₹11 Lakh -₹14 Lakh -₹9 Lakh
Total Comprehensive Income ₹37.99 Cr ₹27.11 Cr ₹19.75 Cr ₹15.3 Cr ₹14.18 Cr ₹21.97 Cr ₹11.37 Cr ₹4.63 Cr ₹12.68 Cr ₹8.3 Cr ₹5.31 Cr ₹4.25 Cr
EBITDA (computed) ₹64.08 Cr ₹39.13 Cr ₹31.52 Cr ₹20.65 Cr ₹29.32 Cr ₹24.65 Cr ₹20.98 Cr ₹15.84 Cr ₹25.2 Cr ₹15.42 Cr ₹16.06 Cr ₹15.53 Cr
Basic EPS ₹32.51 ₹18.64 ₹14.40 ₹8.75 ₹11.07 ₹18.02 ₹6.92 ₹3.33 ₹9.36 ₹6.13 ₹4.07 ₹3.25
Diluted EPS ₹32.51 ₹18.64 ₹14.40 ₹8.75 ₹11.07 ₹18.02 ₹6.92 ₹3.33 ₹9.36 ₹6.13 ₹4.07 ₹3.25
Latest 12 quarters shown of 23 on record.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Venus Remedies Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Board & Governance of Venus Remedies Limited

As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Venus Remedies Limited has 10 directors - 5 independent and 5 executive. The board is chaired by PAWAN CHAUDHARY.

DirectorPositionOn board sinceListed boards
PAWAN CHAUDHARY Executive Director · MD · Chairperson 1989-09-15 1
MANU CHAUDHARY Executive Director 2005-10-10 1
PEEYUSH JAIN Executive Director 1994-09-28 1
ASHUTOSH JAIN Executive Director 2007-05-01 1
AKSHANSH CHAUDHARY Executive Director 2022-05-27 1
NAVDEEP SUD Non-Executive - Independent Director 2020-06-20 1
SAVITA GUPTA Non-Executive - Independent Director 2021-12-30 1
NPS MONGA Non-Executive - Independent Director 2023-05-29 1
ANIL KUMAR Non-Executive - Independent Director 2024-08-13 1
JAGDISH CHANDER SHARMA Non-Executive - Independent Director 2024-08-13 1
Board Committees
CommitteeMembers
Audit Committee NPS MONGA (Chairperson), NAVDEEP SUD, PAWAN CHAUDHARY
Nomination and remuneration committee SAVITA GUPTA (Chairperson), NAVDEEP SUD, NPS MONGA
Stakeholders Relationship Committee SAVITA GUPTA (Chairperson), NAVDEEP SUD, PEEYUSH JAIN
Corporate Social Responsibility Committee NPS MONGA (Chairperson), ASHUTOSH JAIN, AKSHANSH CHAUDHARY

Charges & Borrowings of Venus Remedies Limited

Open charges
₹0
Satisfied charges
₹909.48 Cr
Breakdown by lending institutions
State Bank of India₹486.64 Cr
Idbi Bank Limited₹82.00 Cr
Dena Bank₹66.50 Cr
Ifci Limited₹50.00 Cr
Export-Import Bank of India₹50.00 Cr
Others₹174.34 Cr
Latest charge details
DateLenderAmountStatus
10 Feb 2015 Idbi Trusteeship Services Limited ₹16.57 Cr Satisfied
31 Mar 2014 Dena Bank ₹2 Cr Satisfied
09 Jan 2014 Andhra Bank ₹5 Cr Satisfied
09 Jan 2014 Andhra Bank ₹20 Cr Satisfied
26 Nov 2013 Dena Bank ₹14.5 Cr Satisfied

Total charge records: 42 View all charges

Employees and EPFO Compliance at Venus Remedies Limited

View historical data on people associated with Venus Remedies Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Venus Remedies Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Venus Remedies Limited

Premium access

GST registrations and filing compliance for Venus Remedies Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Venus Remedies Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Venus Remedies Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Venus Remedies Limited

Premium access

MSME payment history for Venus Remedies Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Venus Remedies Limited

Premium access

Corporate group structure for Venus Remedies Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Venus Remedies Limited

Premium access

MCA filings and documents for Venus Remedies Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Venus Remedies Limited

Activity
22 Aug 2025
Venus Remedies Limited last Annual general meeting of members was held on 22 Aug 2025 as per latest MCA records.
Activity
31 Mar 2025
Venus Remedies Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Directors
13 Aug 2024
Anil Kumar was appointed as a Director on 13 Aug 2024 & has been associated with this company since 1 year 11 months.
Directors
13 Aug 2024
Jagdish Chander Sharma was appointed as a Director on 13 Aug 2024 & has been associated with this company since 1 year 11 months.
Directors
29 May 2023
Nps Monga was appointed as a Director on 29 May 2023 & has been associated with this company since 3 years 1 month.
Directors
27 May 2022
Akshansh Chaudhary was appointed as a Whole-time director on 27 May 2022 & has been associated with this company since 4 years 1 month.

Recent News on Venus Remedies Limited

Frequently Asked Questions about Venus Remedies Limited

Venus Remedies Limited is an active public limited company in the pharma sector based in Chandigarh, Chandigarh, India. It was incorporated on 15 September 1989 (37+ years old) and is registered under CIN L24232CH1989PLC009705. Listed on BSE: 526953 and NSE: VENUSREM. The company has 1,119 employees.

Venus Remedies Limited reported revenue of ₹769.6 Cr for FY 2026 (up 18.79% YoY) based on consolidated NSE filings.

The current directors of Venus Remedies Limited are:

The primary industry of Venus Remedies Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Yes. Venus Remedies Limited is listed on both BSE (code: 526953) and NSE (symbol: VENUSREM).

Venus Remedies Limited can be reached at the registered office: Sco 857 2Nd Floor C. No. 10 Nac Manimajra, Chandigarh, Chandigarh, India – 160101, or through the website venusremedies.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available